belantamab mafodotin,ciltacabtagene autoleucel,idecabtagene vicleucel
janssen,2seventy bio,bms,gsk
['carvykti', 'blenrep', 'abecma', 'mmsm']
after third relapse, bcma options should be considered. blenrep, abecma or carvykti are all fda approved. #mmsm #asco22 #peerview 
Supporting, educating and connecting #myeloma patients and their loved ones while actively seeking a cure.